Apple Joins Global Fight Against HIV/AIDS with Release of Red iPhone


The smartphone hit the shelves recently.

Last week, Apple released a special edition red iPhone as part of its latest efforts in the fight against HIV/AIDS.

The tech-giant, in a partnership with the (RED) charity, will make a donation from a portion of each device sold to help fund the charity’s work to combat HIV in sub-Saharan Africa.

“Combining the global reach of the world’s most loved smartphone with our efforts to provide access to life-saving ARV [antiretroviral] medication in sub-Saharan Africa,” Deborah Dugan, CEO of (RED), said in a press release. “Customers now have a remarkable opportunity to make a difference and contribute to the Global Fund through the purchase of this new beautiful (PRODUCT)RED iPhone.”

To-date, Apple has donated approximately $130 million to fight HIV, and is the largest corporate donor to the fund, according to Dugan.

Apple stated that every (RED) purchase contributes directly to the Global Fund to Fight AIDS, but it remains unclear exactly how much of the profits will go to the charity.

The models start at $749 for the iPhone 7 and $869 for the Plus.

“For 10 years, our partnership with (RED) has supported HIV/AIDS programs that provide counseling, testing, and medicine that prevents the transmission of HIV from a mother to her unborn child,” Apple wrote on its site. “So far, we’ve raised over $130 million through the sale of our (RED) products. Now we’re introducing iPhone 7 (PRODUCT)RED Special Edition. Every purchase brings us a step closer to an AIDS-free generation.”

Related Videos
Image Credit: SciePro -
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 -
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская |
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages -
Image credit: alicja neumiler |
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
© 2024 MJH Life Sciences

All rights reserved.